These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 367038)

  • 21. Is DH-ergotoxine the best gerontologicum from the ergot source? Experimental comparison with individual components.
    Grossmann V; Hrdina R; Jezek J; Cech M; Jarkovská I; Nemeitová M
    Act Nerv Super (Praha); 1984 Sep; 26(3):195-201. PubMed ID: 6542291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trazodone in the treatment of organic brain syndromes, with special reference to psychogeriatrics.
    Nair NP; Ban TA; Hontela S; Clarke R
    Curr Ther Res Clin Exp; 1973 Oct; 15(10):769-75. PubMed ID: 4201974
    [No Abstract]   [Full Text] [Related]  

  • 23. [Controlled clinical trial of dihydroergocristine in neuropsychiatric disorders in cerebrovascular insufficiency].
    Muchnik S
    Boll Chim Farm; 1982 May; 121(5):33S-46S. PubMed ID: 6814466
    [No Abstract]   [Full Text] [Related]  

  • 24. [Psychiatric symptoms masking vascular disorders and encephalopathies].
    Kugler J; Ross A; Kollmannsberger A
    Wien Klin Wochenschr; 1969 Mar; 81(13):234-7. PubMed ID: 5780944
    [No Abstract]   [Full Text] [Related]  

  • 25. [Dihydroergocristine in organic brain psychosyndrome. Multicenter placebo-controlled clinical double-blind study in 240 patients].
    Lazzaroni M; Cattalini C; Massetto N; Poli A
    Arzneimittelforschung; 1992 Nov; 42(11A):1410-3. PubMed ID: 1492864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind trial of suloctidil versus placebo in moderate to severe mental deterioration.
    Baro F; Malfroid M; Waegemans T; Cox JP
    Pharmatherapeutica; 1985; 4(6):399-404. PubMed ID: 3001778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic effects of pindolol on behavioral disturbances associated with organic brain disease: a double-blind study.
    Greendyke RM; Kanter DR
    J Clin Psychiatry; 1986 Aug; 47(8):423-6. PubMed ID: 3525523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nylidrin HCL in the treatment of symptoms of the aged: a double-blind placebo controlled study.
    Goldstein SE; Birnbom F
    J Clin Psychiatry; 1979 Dec; 40(12):520-4. PubMed ID: 500575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Organic causes of secondary psychoses].
    Peters UH; Gille G
    Dtsch Med Wochenschr; 1973 May; 98(19):967-70. PubMed ID: 4701108
    [No Abstract]   [Full Text] [Related]  

  • 30. Transient global amnesia: a personal series of 60 cases.
    Cattaino G
    Ital J Neurol Sci; 1988 Apr; Suppl 9():21-2. PubMed ID: 3170164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of disorders of cerebral performance in the aged in ambulatory care using bencyclane. Results of a controlled double-blind phase III study versus placebo].
    Garweg G; Herrmann WM; Kern U
    Z Gerontol; 1987; 20(1):56-62. PubMed ID: 3554804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [On acute psychoses during transitory cerebral irculatory disorders].
    Tatarenko NP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(6):863-7. PubMed ID: 5364237
    [No Abstract]   [Full Text] [Related]  

  • 33. [A double-blind comparison of a sulfurated mucopolysaccharide and placebo in the treatment of elderly patients with cerebrovascular insufficiency].
    Astengo F; Fontana L; Balestreri R
    Clin Ter; 1987 Feb; 120(3):219-26. PubMed ID: 2461828
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical use of phospholipids from bovine brains in patients with cerebrovascular disorders and syndromes following commotio and contusio cerebri].
    Bokonjic R
    Munch Med Wochenschr; 1973 Oct; 115(41):1807-11. PubMed ID: 4800929
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical responses to Cinnarizin in various psychiatric syndromes.
    Szobor A; Klein M
    Ther Hung; 1973; 21(1):31-4. PubMed ID: 4792889
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pathogenic factors and the anatomic basis of vascular psychoses].
    Kushelev VP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(7):1032-7. PubMed ID: 4544281
    [No Abstract]   [Full Text] [Related]  

  • 37. [Experiences on the treatment of cerebral insufficiency and peripheral circulation disorders with the test preparation EP 50-100].
    Bock KJ
    Med Welt; 1972 Feb; 23(8):273-5. PubMed ID: 5012543
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical and psychological experience with a geratric drug].
    Bruck J; Maly J; Quatember R; Tschabitscher H
    Wien Med Wochenschr; 1972 Dec; 122(50):747-53. PubMed ID: 4568234
    [No Abstract]   [Full Text] [Related]  

  • 39. [The use of Wittenborn psychiatric rating scales in geriatric psychiatry. Results of a double blind study with cyprodenate and placebo].
    Bergener M; Freistein H
    Arzneimittelforschung; 1972 Dec; 22(12):2058-63. PubMed ID: 4575344
    [No Abstract]   [Full Text] [Related]  

  • 40. [Drug-related increase of intelligence level. Considerations and a double-blind-study with flunarizin (sibelium) (author's transl)].
    Lehrl S; Sollberg G; Schumacher H
    Pharmakopsychiatr Neuropsychopharmakol; 1978 May; 11(3):134-46. PubMed ID: 353832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.